Top

Graefe's Archive for Clinical and Experimental Ophthalmology

27-01-2024 | Laser | Mini Review

Subthreshold laser treatment in retinal diseases: a mini review

Authors: Andrzej Grzybowski, Zuzana Sulaviková, Maciej Gawęcki, Igor Kozak

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology

Abstract

Purpose

To summarize the mechanism and the clinical applications of subthreshold laser (STL) in retinal practice. Subthreshold or “non-destructive” laser includes all types of laser treatments that produce minimal or no damage to the tissues and no visible signs after application.

Methods

A descriptive review of articles from literature databases (PubMed, Medline, Embase, Cochrane, Web of Science) published before August 2023, which discuss current STL treatments of retinal diseases.

Results

This review provides evidence for STL as a treatment option for central serous chorioretinopathy, diabetic retinopathy, age-related macular degeneration, macular edema due to retinal vein occlusion, and other maculopathies. In most published reports, STL has shown a therapeutic effect without damage to the underlying tissue.

Conclusion

Subthreshold laser treatment has shown safety and efficacy in the management of some retinal and macular diseases. Stimulation of the retinal pigment epithelium without destroying adjacent neuroretina has been shown to be sufficient in inducing retinal repair in many clinical cases. Recent research and clinical studies continue to explore the mechanisms and improving therapeutic benefits of this technology as well as extend the range of retinal disorders treatable by this modality.

Gawęcki M (2019) Micropulse laser treatment of retinal diseases. J Clin Med 8:242. https://doi.org/10.3390/jcm8020242CrossRefPubMedPubMedCentral

Kozak I, Luttrull JK (2015) Modern retinal laser therapy. Saudi J Ophthalmol 29:137–146. https://doi.org/10.1016/j.sjopt.2014.09.001CrossRefPubMed

Lavinsky D, Wang J, Huie P, Dalal R, Lee SJ, Lee DY, Palanker D (2016) Nondamaging retinal laser therapy: rationale and applications to the macula. Invest Ophthalmol Vis Sci 57:2488–2500. https://doi.org/10.1167/iovs.15-18981CrossRefPubMedPubMedCentral

Sramek C, Mackanos M, Spitler R, Leung LS, Nomoto H, Contag CH, Palanker D (2011) Non-damaging retinal phototherapy: dynamic range of heat shock protein expression. Invest Ophthalmol Vis Sci 52:1780–1787. https://doi.org/10.1167/iovs.10-5917CrossRefPubMed

Grzybowski A, Luttrull JK, Kozak I (2023) Retina lasers in ophthalmology. Springer, Berlin, pp 37–341CrossRef

Inagaki K, Shuo T, Katakura K (2015) Sublethal photothermal stimulation with a micropulse laser induces heat shock protein expression in ARPE-19 cells. J Ophthalmol 729792. https://doi.org/10.1155/2015/729792

Luttrull JK, Chang DB, Margolis BW, Dorin G, Luttrull DK (2015Jun) Laser resensitization of medically unresponsive neovascular age-related macular degeneration: efficacy and implications. Retina 35(6):1184–1194. https://doi.org/10.1097/IAE.0000000000000458CrossRefPubMed

Sivaprasad S, Elagouz M, McHugh D, Shona O, Dorin G (2010) Micropulsed diode laser therapy: evolution and clinical applications. Surv Ophthalmol 55:516–530. https://doi.org/10.1016/j.survophthal.2010.02.005CrossRefPubMed

Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I, Behar-Cohen F (2017Oct) Acute central serous chorioretinopathy: factors influencing episode duration. Retina 37(10):1905–1915. https://doi.org/10.1097/IAE.0000000000001443CrossRefPubMedPubMedCentral

10.

Luttrull JK (2016) Low-intensity/high-density subthreshold diode micropulse laser for central serous chorioretinopathy. Retina 36:1658–1663. https://doi.org/10.1097/IAE.0000000000001005CrossRefPubMed

11.

Scholz P, Ersoy L, Boon CJ, Fauser S (2015) Subthreshold micropulse laser (577 nm) treatment in chronic central serous chorioretinopathy. Ophthalmologica 234:189–194. https://doi.org/10.1159/000439600CrossRefPubMed

12.

Ambiya V, Kumar A (2020) Role of 532 nm transfoveal subthreshold micropulse laser in non-resolving central serous chorioretinopathy with subfoveal leaks. Ther Adv Ophthalmol 12. https://doi.org/10.1177/251584142094510

13.

Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A, Grzybowski A (2017) Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser. Graefes Arch Clin Exp Ophthalmol 255:2299–2306. https://doi.org/10.1007/s00417-017-3783-xCrossRefPubMedPubMedCentral

14.

Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A, Kneba M, Grzybowski A (2019Sep 6) Transfoveal micropulse laser treatment of central serous chorioretinopathy within six months of disease onset. J Clin Med 8(9):1398. https://doi.org/10.3390/jcm8091398CrossRefPubMedPubMedCentral

15.

Gawęcki M, Grzybowski A (2023) Lasers in the treatment of central serous chorioretinopathy. In: Grzybowski A, Luttrull JK, Kozak I (eds) Retina lasers in ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-031-25779-7_6CrossRef

16.

Keunen JEE, Battaglia-Parodi M, Vujosevic S, Luttrull JK (2020) International retinal laser society guidelines for subthreshold laser treatment. Trans Vis Sci Tech 9. https://doi.org/10.1167/tvst.9.9.15

17.

Ntomoka CG, Rajesh B, Muriithi GM, Goud A, Chhablani J (2018) Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy. Eye 32:1079–1086. https://doi.org/10.1038/s41433-018-0029-zCrossRefPubMedPubMedCentral

18.

Scholz P, Altay L, Fauser S (2016) Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy. Eye 30:1371–1377. https://doi.org/10.1038/eye.2016.142CrossRefPubMedPubMedCentral

19.

Özmert E, Demirel S, Yanık Ö, Batıoğlu F (2016) Low-fluence photodynamic therapy versus subthreshold micropulse yellow wavelength laser in the treatment of chronic central serous chorioretinopathy. J Ophthalmol 3513794. https://doi.org/10.1155/2016/3513794

20.

Van Dijk EHC, Fauser S, Breukink MB et al (2018) Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial. Ophthalmology 125:1547–1555. https://doi.org/10.1016/j.ophtha.2018.04.021CrossRefPubMed

21.

Kim M, Jeon SH, Lee JY, Lee SH, Roh YJ (2022) Factors predicting response to selective retina therapy in patients with chronic central serous chorioretinopathy. J Clin Med 11:323. https://doi.org/10.3390/jcm11020323CrossRefPubMedPubMedCentral

22.

Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, Jonas J, Larsen M, Tadayoni R, Loewenstein A (2017) Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica 237:185–222. https://doi.org/10.1159/00045853CrossRefPubMed

23.

Frizziero L, Calciati A, Torresin T, Midena G, Parrozzani R, Pilotto E, Midena E (2021) Diabetic macular edema treated with 577-nm subthreshold micropulse laser: a real-life, long-term study. J Pers Med 11:405. https://doi.org/10.3390/jpm11050405CrossRefPubMedPubMedCentral

24.

Vujosevic S, Toma C, Villani E, Brambilla M, Torti E, Leporati F, Muraca A, Nucci P, De Cilla S (2020) Subthreshold micropulse laser in diabetic macular edema: 1-year improvement in OCT/OCT-angiography biomarkers. Transl Vis Sci Technol 9:31. https://doi.org/10.1167/tvst.9.10.31CrossRefPubMedPubMedCentral

25.

Chen G, Tzekov R, Li W, Jiang F, Mao S, Tong Y (2016) Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema: a meta-analysis of randomized controlled trials. Retina 36:2059–2065. https://doi.org/10.1097/IAE.0000000000001053CrossRefPubMed

26.

Scholz P, Altay L, Fauser S (2017) A review of subthreshold micropulse laser for treatment of macular disorders. Adv Ther 34:1528–1555. https://doi.org/10.1007/s12325-017-0559-yCrossRefPubMedPubMedCentral

27.

Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, Jonas J, Larsen M, Tadayoni R, Loewenstein A (2017) Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica 237(4):185–222. https://doi.org/10.1159/000458539CrossRefPubMed

28.

Vujosevic S, Gatti V, Muraca A, Brambilla M, Villani E, Nucci P, Rossetti L, De Cilla’ S. (2020) Optical coherence tomography angiography changes after subthreshold micropulse yellow laser in diabetic macular edema. Retina 40(2):312–321CrossRefPubMed

29.

Gawęcki M (2021) Subthreshold diode micropulse laser combined with intravitreal therapy for macular edema-a systematized review and critical approach. J Clin Med 10:1394. https://doi.org/10.3390/jcm10071394CrossRefPubMedPubMedCentral

30.

Moisseiev E, Abbassi S, Thinda S, Yoon J, Yiu G, Morse LS (2018) Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema. Eur J Ophthalmol 28:68–73. https://doi.org/10.5301/ejo.5001000CrossRefPubMed

31.

Kim M, Park YG, Jeon SH, Choi SY, Roh YJ (2020) The efficacy of selective retina therapy for diabetic macular edema based on pretreatment central foveal thickness. Lasers Med Sci 35:1781–1790. https://doi.org/10.1007/s10103-020-02984-6CrossRefPubMed

32.

Gass JD (1971) Photocoagulation of macular lesions. Trans Am Acad Ophthalmol Otolaryngol May-Jun 75(3):580–608

33.

Abdelsalam A, Del Priore L, Zarbin MA (1999) Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol Jul-Aug 44(1):1–29CrossRef

34.

Gass JD, Agarwal A, Lavina AM, Tawansy KA (2003) Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 23(6):741–51CrossRefPubMed

35.

Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial (1998) The Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology 105(8):1364–72CrossRef

36.

Owens SL, Bunce C, Brannon AJ, Wormald R, Bird AC, Drusen Laser Study Group (2003) Prophylactic laser treatment appears to promote choroidal neovascularisation in high-risk ARM: results of an interim analysis. Eye (Lond) 17(5):623–7CrossRefPubMed

37.

Bressler NM, Maguire MG, Murphy PL, Alexander J, Margherio R, Schachat AP, Fine SL, Stevens TS, Bressler SB (1996) Macular scatter (‘grid’) laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Arch Ophthalmol 114:1456–1464. https://doi.org/10.1001/archopht.1996.01100140654002CrossRefPubMed

38.

Luttrull JK, Sinclair SH, Elmann S, Glaser BM (2018) Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD. PLoS One 23(13):e0202097. https://doi.org/10.1371/journal.pone.0202097CrossRef

39.

Luttrull JK, Sinclair SH, Elmann S, Chang DB, Kent D (2020) Slowed progression of age-related geographic atrophy following subthreshold laser. Clin Ophthalmol 14:2983–2993. https://doi.org/10.2147/OPTH.S268322CrossRefPubMedPubMedCentral

40.

Huang Z, Deng KY, Deng YM, Hui YN, Song YP (2022) Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a preliminary clinical study. Int J Ophthalmol 15:474–482. https://doi.org/10.18240/ijo.2022.03.16CrossRefPubMedPubMedCentral

41.

Querques G, Sacconi R, Gelormini F, Borrelli E, Prascina F, Zucchiatti I, Querques L, Bandello F (2021) Subthreshold laser treatment for reticular pseudodrusen secondary to age-related macular degeneration. Sci Rep 11:2193. https://doi.org/10.1038/s41598-021-81810-7CrossRefPubMedPubMedCentral

42.

Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, McGuinness MB, Fletcher EL, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Lek JJ, Harper CA, Wickremasinghe SS, Sandhu SS, Baglin EK, Sharangan P, Braat S, Luu CD (2018) Laser Intervention in Early Stages of Age-Related Macular Degeneration Study Group. Subthreshold nanosecond laser intervention in age-related macular degeneration: the LEAD randomized controlled clinical trial. Ophthalmology 126:829–838. https://doi.org/10.1016/j.ophtha.2018.09.015CrossRefPubMed

43.

Wu Z, Luu CD, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, Harper CA, Wickremasinghe SS, Sandhu SS, McGuinness MB, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Wintergerst MWM, Gorgi Zadeh S, Schultz T, Finger RP, Cohn AC, Baglin EK, Sharangan P, Guymer RH, LEAD Study Group (2019) Secondary and exploratory outcomes of the subthreshold nanosecond laser intervention randomized trial in age-related macular degeneration: a LEAD study report. Ophthalmol Retina 3(12):1026–1034CrossRefPubMed

44.

Prahs P, Walter A, Regler R, Theisen-Kunde D, Birngruber R, Brinkmann R, Framme C (2010) Selective retina therapy (SRT) in patients with geographic atrophy due to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 248:651–658. https://doi.org/10.1007/s00417-009-1208-1CrossRefPubMed

45.

Eng VA, Leng T (2020) Subthreshold laser therapy for macular oedema from branch retinal vein occlusion: focused review. Br J Ophthalmol 104:1184–1189. https://doi.org/10.1136/bjophthalmol-2019-315192)CrossRefPubMed

46.

Verdina T, D’Aloisio R, Lazzerini A, Ferrari C, Valerio E, Mastropasqua R, Cavallini GM (2020) The role of subthreshold micropulse yellow laser as an alternative option for the treatment of refractory postoperative cystoid macular edema. J Clin Med 9:1066CrossRefPubMedPubMedCentral

47.

Minowa Y, Ohkoshi K, Ozawa Y (2021) Subthreshold laser treatment for serous retinal detachment associated with tilted disk syndrome. Case Rep Ophthalmol 12:978–986. https://doi.org/10.1159/000520570CrossRefPubMedPubMedCentral

48.

Luttrull JK (2020) Subthreshold diode micropulse laser (SDM) for persistent macular thickening and limited visual acuity after epiretinal membrane peeling. Clin Ophthalmol 14:1177–1188. https://doi.org/10.2147/OPTH.S251429CrossRefPubMedPubMedCentral

Title: Subthreshold laser treatment in retinal diseases: a mini review
Authors: Andrzej Grzybowski
Zuzana Sulaviková
Maciej Gawęcki
Igor Kozak
Publication date: 27-01-2024
Publisher: Springer Berlin Heidelberg
Keywords: Laser
Retinal Diseases
Edema
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-024-06382-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Subthreshold laser treatment in retinal diseases: a mini review

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content